Mean Ct values of positive samples (number of positive samples/ number of samples) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Days post challenge | Days post-farrow | ||||||||||
Sample type | Group | -3 | 0 | 7 | 14 | 21 | 0 | 2 | 9 | 16 | 21–25 |
Faecal swab | Untreated-unchallenged | ns | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/5) | nd (0/5) | nd (0/5) | nd (0/5) |
Untreated-challenged | ns | nd (0/6) | 30.1 (4/6) | 34.6 (4/6) | 33.6 (3/6) | 34.1 (4/6) | 33.4 (1/6) | 31.7 (1/6) | nd (0/6) | nd (0/6) | |
Treated-challengeda | ns | nd (0/6) | 30.6 (3/6) | 33.3 (3/6) | 32.4 (1/5) | 33.5 (4/5) | 31.6 (2/5) | 32.4 (2/5) | nd (0/5) | nd (0/5) | |
Oral swab | Untreated-unchallenged | ns | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/5) | nd (0/5) | nd (0/5) | nd (0/5) |
Untreated-challenged | ns | nd (0/6) | 33.4 (4/6) | 35.4 (1/6) | nd (0/6) | nd (0/6) | 36.0 (1/6) | nd (0/6) | 36.8 (1/6) | nd (0/6) | |
Treated-challengeda | ns | nd 0/6) | 32.9 (3/6) | nd (0/6) | nd (0/5) | 35.7 (1/5) | 33.8 (1/5) | nd (0/5) | nd (0/5) | nd (0/5) | |
Blood serum | Untreated-unchallenged | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/6) | nd (0/5) | nd (0/5) | nd (0/5) |
Untreated-challenged | nd (0/5) | nd (0/6) | 25.8 (6/6) | 32.1 (6/6) | 32.6 (6/6) | 33.3 (5/6) | 33.4 (4/6) | nd (0/6) | nd (0/6) | 36.4 (2/6) | |
Treated-challengeda | nd (0/6) | nd (0/6) | 25.4 (6/6) | 32.7 (6/6) | 33.2 (4/5) | 34.1 (4/5) | 32.9 (3/5) | 35.6 (2/5) | 34.3 (2/5) | 31.9. (1/5) |